18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment : a phase 2 trial.
Abstract
The most widely studied positron emission tomography ligand for in vivo beta-amyloid imaging is (11)C-Pittsburgh compound B ((11)C-PIB). Its availability, however, is limited by the need for an on-site cyclotron. Validation of the (18)F-labeled PIB derivative (18)F-flutemetamol could significantly enhance access to this novel technology- info:eu-repo/semantics/article
- Aged
- Alzheimer Disease - radionuclide imaging
- Radiopharmaceuticals - diagnostic use
- Sensitivity and Specificity
- Benzothiazoles - diagnostic use
- Brain - metabolism, radionuclide imaging
- Cognition Disorders - radionuclide imaging
- Diagnostic Imaging
- Fluorodeoxyglucose F18 - analogs & derivatives, diagnostic use
- Humans
- Middle Aged
- Positron-Emission Tomography - methods
Similar works
This paper was published in DIAL UCLouvain.
Having an issue?
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.